SCHEMBL24419699

SCHEMBL24419699

COc1ccc(-c2nc(-c3ccc(CO)cc3O)nc(-c3ccc(OC(C)C)cc3O)n2)c(O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.51
MAPT P10636 4/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PTGES O14684 1/20 0.40
ALOX5 P09917 1/20 0.40
LMNA P02545 1/20 0.39
MAPK1 P28482 3/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
POLB P06746 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
MAPK10 P53779 1/20 0.38
PTK2B Q14289 1/20 0.38
NCOA1 Q15788 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29660560 0.83 NPC1 (0.51) NPC1MAPTALDH1A1KMT2ALMNA
SCHEMBL995436 0.83 NPC1 (0.51) NPC1MAPTALDH1A1KMT2ALMNA
SCHEMBL17917593 0.82 NPC1 (0.51) NPC1MAPTALDH1A1MEN1KMT2A
SCHEMBL7987919 0.80 NPC1 (0.50) NPC1MAPTALDH1A1KMT2ACYP3A4
SCHEMBL26927681 0.79 FFAR1 (0.50) NPC1MAPTALDH1A1NPSR1KDM4E
SCHEMBL13030444 0.78 NPC1 (0.77) NPC1MAPTALDH1A1MEN1KMT2A
SCHEMBL13962689 0.77 NPC1 (0.58) NPC1MAPTALDH1A1MEN1KMT2A
SCHEMBL7987794 0.76 MCL1 (0.49) NPC1MAPTALDH1A1KMT2ALMNA
SCHEMBL12755325 0.76 NPC1 (0.45) NPC1MAPTALDH1A1MEN1KMT2A
SCHEMBL14998005 0.75 APP (0.44) NPC1MAPTMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144785-A1 COMPOUNDS HAVING EXCITED STATE INTRAMOLECULAR PROTON TRANSFER (ESIPT) CHARACTER FOR USE IN TREATING AND/OR PREVENTING SUNBURN AND/OR PREVENTING U.V. DAMAGE UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG (ZA) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144785-A1 COMPOUNDS HAVING EXCITED STATE INTRAMOLECULAR PROTON TRANSFER (ESIPT) CHARACTER FOR USE IN TREATING AND/OR PREVENTING SUNBURN AND/OR PREVENTING U.V. DAMAGE NNT, NQO1, SUN2 NPC1 482/4885MAPT 113/4885ALDH1A1 2187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.